tiprankstipranks
Hemagen Diagnostics Inc (HMGN)
OTHER OTC:HMGN
US Market

Hemagen Diagnostics (HMGN) Price & Analysis

4 Followers

HMGN Stock Chart & Stats

$0.02
$0.00(0.00%)
At close: 4:00 PM EDT
$0.02
$0.00(0.00%)

HMGN FAQ

What was Hemagen Diagnostics Inc’s price range in the past 12 months?
Hemagen Diagnostics Inc lowest stock price was $0.01 and its highest was $0.04 in the past 12 months.
    What is Hemagen Diagnostics Inc’s market cap?
    Hemagen Diagnostics Inc’s market cap is $3.10K.
      When is Hemagen Diagnostics Inc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Hemagen Diagnostics Inc’s earnings last quarter?
      Currently, no data Available
      Is Hemagen Diagnostics Inc overvalued?
      According to Wall Street analysts Hemagen Diagnostics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Hemagen Diagnostics Inc pay dividends?
        Hemagen Diagnostics Inc does not currently pay dividends.
        What is Hemagen Diagnostics Inc’s EPS estimate?
        Hemagen Diagnostics Inc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Hemagen Diagnostics Inc have?
        Hemagen Diagnostics Inc has 15,500,000 shares outstanding.
          What happened to Hemagen Diagnostics Inc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Hemagen Diagnostics Inc?
          Currently, no hedge funds are holding shares in HMGN
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Hemagen Diagnostics Inc

            Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase proteins. Its comprehensive human diagnostic portfolio also encompasses Universal IFA components, various supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialized assays covering conditions such as Chagas, acute phase proteins, and cytokines. For the veterinary market, Hemagen Diagnostics provides diagnostic equipment, reagents, consumables, accessories, and electrodes crucial for chemistry, hematology, and electrolyte analysis. The company reaches a diverse customer base, including laboratories, hospitals, and blood banks, through both direct sales and an extensive distribution network. Established in 1985, Hemagen Diagnostics maintains its headquarters in Columbia, Maryland.
            Similar Stocks
            Company
            Price & Change
            Follow
            Co-Diagnostics
            Cardio Diagnostics Holdings

            Ownership Overview

            0.33%99.67%
            Insiders
            Mutual Funds
            0.33% Other Institutional Investors
            99.67% Public Companies and
            Individual Investors
            Popular Stocks